# | Title | Journal | Year | Citations |
---|
1 | A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats | Life Sciences | 1981 | 2,879 |
2 | Antioxidant activity and phenolic compounds of 112 traditional Chinese medicinal plants associated with anticancer | Life Sciences | 2004 | 2,045 |
3 | Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine | Life Sciences | 1977 | 1,855 |
4 | Biological effects of resveratrol | Life Sciences | 2000 | 1,374 |
5 | Multiple biological activities of curcumin: A short review | Life Sciences | 2006 | 1,365 |
6 | SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged action | Life Sciences | 1982 | 1,221 |
7 | Free Cortisol Levels after Awakening: A Reliable Biological Marker for the Assessment of Adrenocortical Activity | Life Sciences | 1997 | 1,200 |
8 | Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent behavior | Life Sciences | 1983 | 1,194 |
9 | Drug discovery from medicinal plants | Life Sciences | 2005 | 1,182 |
10 | Simultaneous radioenzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine within the femtomole range | Life Sciences | 1976 | 1,177 |
11 | Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine | Life Sciences | 1985 | 1,144 |
12 | Men and mice: Relating their ages | Life Sciences | 2016 | 1,093 |
13 | iNOS-mediated nitric oxide production and its regulation | Life Sciences | 2004 | 1,073 |
14 | Flavonoids: Old and new aspects of a class of natural therapeutic drugs | Life Sciences | 1999 | 1,029 |
15 | Tea polyphenols for health promotion | Life Sciences | 2007 | 896 |
16 | Two dopamine receptors: Biochemistry, physiology and pharmacology | Life Sciences | 1984 | 888 |
17 | Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor | Life Sciences | 1992 | 841 |
18 | Chemical constituents of marijuana: The complex mixture of natural cannabinoids | Life Sciences | 2005 | 826 |
19 | Receptor binding profile of R 41 468, A novel antagonist at 5-HT2 receptors | Life Sciences | 1981 | 821 |
20 | A functional basis for classification of α-adrenergic receptors | Life Sciences | 1977 | 779 |
21 | Antioxidant and antiradical activities of l-carnitine | Life Sciences | 2006 | 773 |
22 | Free radical scavenging activities of mushroom polysaccharide extracts | Life Sciences | 1997 | 764 |
23 | Oxidative stress and metabolic disorders: Pathogenesis and therapeutic strategies | Life Sciences | 2016 | 758 |
24 | Demonstration and mapping out of nigro-neostriatal dopamine neurons | Life Sciences | 1964 | 737 |
25 | Liquid chromatographic analysis of catecholamines routine assay for regional brain mapping | Life Sciences | 1976 | 727 |
26 | Omega-3 and omega-6 polyunsaturated fatty acids: Dietary sources, metabolism, and significance — A review | Life Sciences | 2018 | 719 |
27 | Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study | Life Sciences | 2020 | 717 |
28 | Stress- and treatment-induced elevations of cortisol levels associated with impaired declarative memory in healthy adults | Life Sciences | 1996 | 705 |
29 | Oxidative stress and metabolic syndrome | Life Sciences | 2009 | 691 |
30 | Muscarinic receptor subtypes: M1 and M2 biochemical and functional characterization | Life Sciences | 1982 | 679 |
31 | Structure–radical scavenging activity relationships of phenolic compounds from traditional Chinese medicinal plants | Life Sciences | 2006 | 676 |
32 | Green tea and its polyphenolic catechins: Medicinal uses in cancer and noncancer applications | Life Sciences | 2006 | 673 |
33 | II. New evidence for a locus coeruleus-norepinephrine connection with anxiety | Life Sciences | 1979 | 657 |
34 | On the specificity of naloxone as an opiate antagonist | Life Sciences | 1979 | 626 |
35 | Neuroreptide Y: Stimulation of feeding and drinking by injection into the paraventricular nucleus | Life Sciences | 1984 | 622 |
36 | Postnatal disappearance of the pregnancy-associated reduced sensitivity of plasma cortisol to feedback inhibition | Life Sciences | 1987 | 596 |
37 | Melatonin: A peroxyl radical scavenger more effective than vitamin E | Life Sciences | 1994 | 589 |
38 | Effects of naloxone, morphine and methionine enkephalin on serum prolactin, luteinizing hormone, follicle stimulating hormone, thyroid stimulating hormone and growth hormone | Life Sciences | 1977 | 582 |
39 | A critical physiological role of zinc in the structure and function of biomembranes | Life Sciences | 1981 | 573 |
40 | The role of calcium in cell death | Life Sciences | 1981 | 572 |
41 | Determination of plasma catecholamines by high performance liquid chromatography with electrochemical detection: Comparison with a radioenzymatic method | Life Sciences | 1979 | 564 |
42 | Naloxone blockade of acupuncture analgesia: Endorphin implicated | Life Sciences | 1976 | 561 |
43 | Prozac (fluoxetine, lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: Twenty years since its first publication | Life Sciences | 1995 | 556 |
44 | Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatum | Life Sciences | 1984 | 549 |
45 | A simple and rapid method for injecting H3-norepinephrine into the lateral ventricle of the rat brain | Life Sciences | 1967 | 547 |
46 | An animal behavior model for studying central serotonergic synapses | Life Sciences | 1976 | 547 |
47 | Binding of antipsychotic drugs to human brain receptors | Life Sciences | 2000 | 547 |
48 | Quantitative analysis of drug-receptor interactions: I. Determination of kinetic and equilibrium properties | Life Sciences | 1981 | 546 |
49 | Kainic acid as a tool for the study of temporal lobe epilepsy | Life Sciences | 1981 | 546 |
50 | Anti-HCV, nucleotide inhibitors, repurposing against COVID-19 | Life Sciences | 2020 | 546 |